Padilla, Carlos J.
Harrigan, Markus E.
Harris, Hallie
Schwab, Jan M.
Rutkove, Seward B.
Rich, Mark M.
Clark, Brian C.
Arnold, W. David http://orcid.org/0000-0001-9889-7036
Funding for this research was provided by:
National Institute on Aging (R56AG055795, R01AG044424)
National Institute on Disability, Independent Living, and Rehabilitation Research (90SI5020)
National Institute of Neurological Disorders and Stroke (R01NS118200-01, R01AR074985)
European Union Era Net – Neuron Program (SILENCE Grant 01EW170A)
Craig H. Neilsen Foundation (596764)
Wings for Life
William E. and Josephine B. Buchanan Family Foundation
Article History
Received: 22 February 2021
Accepted: 19 April 2021
First Online: 24 April 2021
Change Date: 13 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11357-021-00464-5
Declarations
:
: All procedures were approved and performed in accordance with the Institutional Animal Care and Use Committee of The Ohio State University.
: SBR has equity in, and serves a consultant and scientific advisor to, Myolex Inc., a company that designs impedance devices for clinical and research use; he is also a member of the company’s Board of Directors. The company also has an option to license patented impedance technology for which SBR is named as an inventor. In the past 3 years, BCC and WDA have received research funding from NMD Pharma for aging muscle research; BCC has received funding from Astellas Pharma Global Development, Inc. for aging muscle research; and BCC has served as a consultant to Regeneron Pharmaceuticals for topics pertinent to aging muscle research.